FDA Homepage

FDA Lapse in Funding

In the absence of either an FY 2019 appropriation or a Continuing Resolution for FDA, beginning on December 22, 2018 and continuing until the date of enactment of an FY 2019 appropriation or Continuing Resolution ("lapse period"), agency operations continue to the extent permitted by law, such as activities necessary to address imminent threats to the safety of human life and activities funded by carryover user fee funds. Read more

New Information for FDA Employees

** BREAKING NEWS: Please be advised FDA is required to issue updated formal notices to all employees. For more information click HERE. **

On January 16th, S.24 was signed into law. The Government Employee Fair Treatment Act of 2019, guarantees that federal workers who are furloughed or working without pay will be compensated for the period of the appropriations lapse beginning December 22, 2018. Employees will be paid retroactively once a FY19 appropriation or Continuing Resolution is approved. For more information click HERE

If you are an FDA employee with a question about the current lapse in appropriations funding, please email AskFDA2019@fda.hhs.gov. Depending on your furlough status please continue to monitor insideFDA or FDA.gov for available information on the current lapse in appropriations funding for the FDA. More information for employees




Browse by Audience



This website has been translated to Spanish from English, and is updated often. It is possible that some links will connect you to content only available in English or some of the words on the page will appear in English until translation has been completed (usually within 24 hours). We appreciate your patience with the translation process. In the case of any discrepancy in meaning, the English version is considered official. Thank you for visiting esp.fda.gov/tabaco.

Page Last Updated: 01/18/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English